Compare AU
Compare DRUG vs. IHWL
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare Currency Hedged ETF (DRUG) and the iShares Core MSCI World Ex Aus Esg (Aud Hed) ETF (IHWL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | IHWL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 61 | 43 |
Median incremental investment | $920.50 | $1,653.64 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,892.10 | $3,633.24 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
DRUG | IHWL | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | IHWL.AX was created on 2016-04-22 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the MSCI World Investable Market AUD Hedged Index, before fees and expenses. The index is designed to measure the AUD hedged performance of global, developed market large-, mid- and small-capitalisation companies. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | NVIDIA CORP (9.88 %) MICROSOFT CORP (8.59 %) ALPHABET INC CLASS A (2.79 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Information Technology (27.81 %) Financials (14.85 %) Health Care (11.91 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (74.50 %) Japan (6.43 %) United Kingdom of Great Britain and Northern Ireland (3.39 %) |
Management fee | 0.57 % | 0.19 % |
Key Summary
DRUG | IHWL | |
|---|---|---|
Issuer | BetaShares | iShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | MSCI World IMI 100% Hedged to AUD Net Variant |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.19 % |
Price | $7.95 | $53.43 |
Size | $185.172 million | $534.989 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 3.57 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 28/04/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | IHWL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 61 | 43 |
Median incremental investment | $920.50 | $1,653.64 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,892.10 | $3,633.24 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
DRUG | IHWL | |
|---|---|---|
Pros |
| |
Cons |
|
DRUG | IHWL |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |